NIAGEN BIOSCIENCE, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $206.00K, a 94.51% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $111.00K, a 96.44% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $228.00K, a 93.99% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $152.00K, a 85.43% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $7.25M, a 33.39% increase from fiscal 2024.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $5.43M.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $9.49M, a 130.74% increase from fiscal 2020.
- NIAGEN BIOSCIENCE, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $4.12M, a 286.02% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $206.00K 10-Q · filed 2026-08-04 | $697.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $111.00K 10-Q · filed 2026-05-06 | $4.24M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $7.25M 10-K · filed 2026-03-04 |
| 2025-09-30 | $152.00K 10-Q · filed 2025-11-04 | $10.81M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $3.75M 10-Q · filed 2026-08-04 | $11.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $3.11M 10-Q · filed 2026-05-06 | $8.55M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $5.43M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.04M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $598.00K 10-Q · filed 2025-08-06 | |
| 2021-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $9.49M 10-K · filed 2023-03-08 |
| 2021-09-30 | $341.00K 10-Q · filed 2022-11-02 | $10.62M derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-06-30 | $391.00K 10-Q · filed 2022-08-10 | $10.83M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $8.63M 10-Q · filed 2022-05-12 | $12.62M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $4.12M 10-K · filed 2022-03-14 |
| 2020-09-30 | $547.00K 10-Q · filed 2021-11-03 | $3.32M derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $2.18M 10-Q · filed 2021-08-03 | $3.11M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $132.00K 10-Q · filed 2021-05-06 | $1.09M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.07M 10-K · filed 2021-03-12 |
| 2019-09-30 | $335.00K 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $164.00K 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $107.00K 10-Q · filed 2020-05-18 | |
| 2018-12-31 | $529.00K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $190.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $75.00K 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $255.00K 10-Q · filed 2019-11-12 | |
| 2017-12-30 | $3.04M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $383.05K 10-Q · filed 2017-11-09 | |
| 2017-07-01 | $5.34K 10-Q · filed 2017-11-09 | |
| 2017-04-01 | $6.62K 10-Q · filed 2017-11-09 | |
| 2016-12-31 | $716.61K 10-K · filed 2018-03-15 | |
| 2016-10-01 | $94.23K 10-Q · filed 2016-11-10 | |
| 2016-07-02 | $528.51K 10-Q · filed 2016-11-10 | |
| 2016-04-02 | $93.87K 10-Q · filed 2016-11-10 | |
| 2016-01-02 | $94.85K 10-K · filed 2018-03-15 | |
| 2015-10-03 | $9.66K 10-Q · filed 2015-11-12 | |
| 2015-07-04 | $15.60K 10-Q · filed 2015-11-12 | |
| 2011-12-31 | $26.40K 10-K · filed 2012-03-15 | |
| 2011-07-02 | $7.05K 10-Q · filed 2011-11-10 | |
| 2011-04-02 | $19.35K 10-Q · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |